St. Louis Trust Co Purchases New Stake in Axon Enterprise, Inc $AXON

St. Louis Trust Co bought a new stake in Axon Enterprise, Inc (NASDAQ:AXON) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,524 shares of the biotechnology company’s stock, valued at approximately $866,000.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Evergreen Capital Management LLC lifted its stake in Axon Enterprise by 3.8% in the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after buying an additional 15 shares during the period. NorthCrest Asset Manangement LLC lifted its stake in Axon Enterprise by 5.4% in the third quarter. NorthCrest Asset Manangement LLC now owns 313 shares of the biotechnology company’s stock valued at $223,000 after buying an additional 16 shares during the period. Monte Financial Group LLC lifted its stake in Axon Enterprise by 5.5% in the third quarter. Monte Financial Group LLC now owns 325 shares of the biotechnology company’s stock valued at $233,000 after buying an additional 17 shares during the period. Wealth Alliance LLC lifted its stake in Axon Enterprise by 3.2% in the third quarter. Wealth Alliance LLC now owns 583 shares of the biotechnology company’s stock valued at $419,000 after buying an additional 18 shares during the period. Finally, Commerzbank Aktiengesellschaft FI lifted its stake in Axon Enterprise by 4.5% in the third quarter. Commerzbank Aktiengesellschaft FI now owns 439 shares of the biotechnology company’s stock valued at $316,000 after buying an additional 19 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In other news, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the sale, the insider owned 55,588 shares of the company’s stock, valued at $29,740,135.88. This trade represents a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total value of $5,002,400.00. Following the sale, the chief executive officer directly owned 3,090,997 shares in the company, valued at approximately $1,546,240,339.28. This represents a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 13,855 shares of company stock valued at $7,109,828 over the last 90 days. Insiders own 4.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Barclays cut their target price on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research note on Friday, May 8th. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 3rd. Robert W. Baird set a $800.00 target price on Axon Enterprise in a research note on Wednesday, February 25th. Finally, Wall Street Zen raised Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $712.75.

Axon Enterprise Trading Down 1.0%

NASDAQ AXON opened at $386.00 on Friday. The firm has a market cap of $31.11 billion, a P/E ratio of 155.02, a P/E/G ratio of 7.02 and a beta of 1.44. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The stock’s 50-day moving average is $416.52 and its 200-day moving average is $503.10. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The company had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.Axon Enterprise’s revenue was up 33.7% compared to the same quarter last year. During the same quarter last year, the firm posted $1.47 earnings per share. Sell-side analysts anticipate that Axon Enterprise, Inc will post 1.82 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.